BBA
RNAC icon

Baker Bros. Advisors’s Cartesian Therapeutics RNAC Stock Holding History

Baker Bros. Advisors’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3,125
Closed -$1.24M – 111
2018
Q2 		$1.24M Hold
3,125
– – 0.01% 103
2018
Q1 		$955K Sell
3,125
-6,332
-67% -$1.8M 0.01% 101
2017
Q4 		$2.78M Sell
9,457
-203
-2% -$88.7K 0.02% 92
2017
Q3 		$5.29M Hold
9,660
– – 0.04% 77
2017
Q2 		$5.76M Buy
9,660
+3,803
+65% +$1.68M 0.05% 63
2017
Q1 		$2.52M Hold
5,857
– – 0.02% 84
2016
Q4 		$3.01M Sell
5,857
-108
-2% -$63.1K 0.03% 77
2016
Q3 		$2.55M Hold
5,965
– – 0.02% 88
2016
Q2 		$2.5M Buy
+5,965
New +$2.51M 0.03% 90

Other funds holding RNAC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SRF
Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return